Enhancement of delta aminolevulinic acid-photodynamic therapy in vivo by decreasing tumor pH with glucose and amiloride

Laryngoscope

Volumn 111, Issue 12, 2001, Pages 2205-2213

  Piot, Benoît ^a   Rousset, Nathalie ^a   Lenz, Peter ^a   Eléouet, Sabine ^a   Carré, Jérome ^a   Vonarx, Véronique ^a   Bourré, Ludovic ^a   Patrice, Thierry ^a  

^a NANTES UNIVERSITY HOSPITAL   (France)

Author keywords

Amiloride; Aminolevulinic acid; Cancers; Glucose; PH; Photodynamic therapy

Indexed keywords

AMILORIDE; AMINOLEVULINIC ACID; GLASS FIBER; GLUCOSE; PROTOPORPHYRIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER GRAFT; CANCER GROWTH; CELL STRAIN HT29; COLON CANCER; CONTROLLED STUDY; FLUORESCENCE; HUMAN; HUMAN CELL; MALE; MOUSE; NONHUMAN; PH; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; SPECTROFLUOROMETRY;

EID: 0035213633     PISSN: 0023852X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005537-200112000-00026     Document Type: Article

References (48)

1. Distribution and photosensitizing efficiency of porphyrins induced by applications of exogenous 5-aminolevulinic acid in mice bearing mammary carcinoma
2. Fluorescence distribution and photodynamic effect of ALA-induced PP IX in the DMH rat colonic tumour model
3. Acid pH in tumors and its potential for therapeutic exploitation
4. Glucose administration augments in vivo uptake and phototoxicity of the tumor localising fraction of hematoporphyrin derivative
5. Detection of squamous cell carcinoma of the oral cavity by imaging 5-aminolevulinic acid-induced protoporphyrin IX fluorescence
6. Photodynamic therapy of oral cancer: Photosensitisation with systemic aminolevulinic acid
7. The influence of hypoxia and pH on aminolevulinic acid-induced photodynamic therapy in bladder cancer cells in vitro
8. The pH dependency of protoporphyrin IX formation in cells incubated with 5-aminolevulinic acid
9. pH dependent formation of 5-aminolaevulinic acid-induced protoporphyrin IX in fibrosarcoma cells
10. Spectrofluorometric analysis in vivo: Applications to kinetics of ALA induced fluorescence
11. Oral versus intravenous administration of 5-aminolaevulinic acid for photodynamic therapy
12. Endogenous porphyrin distribution induced by 5-aminolaevulinic acid
13. Sustained high plasma 5-aminolaevulinic acid concentration in a volunteer: No porphyric symptoms
14. Photodynamic therapy with endogenous protoporphyrin IX: Basic principles and present clinical experience
15. Topical photodynamic therapy with endogenous porphyrins after application of 5-aminolevulinic acid: An alternative treatment modality for solar keratoses, superficial squamous cell carcinomas, and basal cell carcinomas?
16. Endogenous protoporphyrin IX: A clinically useful photosensitizer for photodynamic therapy
17. Enhancement of 5-aminolaevulinic acid-induced photodynamic therapy in normal rat colon using hydroxypyridinone iron-chelating agents
18. Tumor pH in mammary human carcinoma
19. Changes in intratumor pH by two heatings
20. The relevance of tumor pH to the treatment of malignant disease
21. Fluorescence spectroscopy of pH in vivo using a dual emission fluophore (C-SNAFL-1)
22. pH and tumor response to hyperthermia
23. Continuous noninvasive monitoring of pH and temperature in rat Walker 256 carcinoma during normoglycemia and hyperglycemia
24. Modification of human tumor pH by elevation of blood glucose
25. In vivo pH measurement and imaging of tumor tissue using a pH-sensitive fluorescent probe (5, 6-carboxyfluorescein): Instrumental and experimental studies
26. Glucose administration combined with photodynamic therapy of cancer improves therapeutic efficacy
27. Amiloride: A potassium-conserving agent new to the USA-mechanism and clinical relevance
28. Enhancement of hyperthermia effect in vivo by amiloride and DIDS
29. Effects of amiloride on tumor growth and intracellular element content of tumor cells in vivo
30. - exchange
31. Regulation of intracellular pH in tumor cell lines: Influence of microenvironmental conditions
32. Reduction of intracellular pH as a possible mechanism for killing cells in acidic regions of solid tumors: Effect of carbonylcyanid-3-chlorophenylhydrazone
33. Intracellular pH changes induced by exposure to weak acids and bases in submandibular cells of early postnatal rats
34. + extrusion processes
35. Inhibition of tumor blood flow at high sugar levels: Effect on tumor pH and hyperthermia
36. + in perfused salivary gland and pancreas
37. HepG2 human hepatocarcinoma cells: An experimental model for photosensitization by endogenous porphyrins
38. In vivo fluorescence kinetics and photodynamic therapy using 5-aminolevulinic acid-induced porphyrin: Increased damage after multiple irradiations
39. Photodynamic ablation of high-grade dysplasia and early cancer in Barrett's esophagus by means of 5-aminolevulinic acid
40. Selective accumulation of endogenously produced porphyrins in a liver metastasis model in rats
41. In vivo kinetics and spectra of 5-aminolevulinic acid-induced fluorescence in an amelanotic melanoma of the hamster
42. In vitro investigation of ALAinduced protoporphyrin IX
43. Characterization of tumorous and normal tissue using a pH-sensitive fluorescence indicator (5, 6-carboxufluorescein) in vivo
44. Cellular uptake and photodynamic effect of hematoporphyrin
45. Uptake of hematoporphyrin derivate by normal and malignant cells: Effect of serum, pH, temperature, and cell size
46. Enhancement of interstitial photodynamic therapy by mitomycin C and EO9 in a mouse tumour model
47. + ionophore nigericin on response of A549 cells to photodynamic therapy and tert-butylhydroperoxide
48. Reduction of intracellular pH is not the mechanism for the synergistic interaction between photodynamic therapy and nigericin